Lewis’ neurodevelopmental model provides a plausible alternative to the brain disease model of addiction (BDMA) that is a dominant perspective in the USA. We disagree with Lewis’ claim that the BDMA is unchallenged within the addiction field but we agree that it provides unduly pessimistic prospects of recovery. We question the strength of evidence for the BDMA provided by animal models and human neuroimaging studies. We endorse Lewis’ framing of addiction as a developmental process underpinned by reversible forms of neuroplasticity. His view is consistent with epidemiological evidence of addicted individuals ‘maturing out’ and recovering from addiction. We do however hold some reservations about Lewis’ model. We do not think that his analysis of the neurobiological evidence is clearly different from that of the BDMA or that his neurodevelopmental model provides a more rigorous interpretation of the evidence than the BDMA. We believe that our understanding of the neurobiology of drug use is too immature to warrant the major role given to it in the BDMA. Our social research finds very mixed support for the BDMA among addicted people and health professionals in Australia. Lewis’ account of addiction requires similar empirical evaluation of its real-world implications.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Fraser, S., D. Moore, and H. Keane. 2014. Habits: remaking addiction. Basingstoke: Springer.
Keane, H. 2002. What’s wrong with addiction? Carlton: Melbourne University Press.
Heyman, G. 2009. Addiction: a disorder of choice. Cambridge: Harvard University Press.
Netherland, J. 2011. “We haven’t sliced open anyone's brain yet”: neuroscience, embodiment and the governance of addiction. In Sociological reflections on the neurosciences, ed. M. Pickersgill and I. Van Keulen, 153–177. Bingley: Emerald.
Reinarman, C., and R. Granfield. 2014. Addiction is not just a brain disease. In Expanding addiction: critical essays, ed. C. Reinarman and R. Granfield, 1–24. New York: Routledge.
Satel, S., and S.O. Lilienfeld. 2014. Addiction and the brain-disease fallacy. Frontiers in Psychiatry 4: 141.
Satel, S., and S.O. Lilienfeld. 2013. Brainwashed: the seductive appeal of mindless neuroscience. New York: Perseus Books Group.
Lewis, M. 2015. The biology of desire: why addiction is not a disease. New York: Scribe Publications.
Kalant, H. 2010. What neurobiology cannot tell us about addiction. Addiction 105: 780–789.
Peele, S. 2010. Addiction in society: blinded by biochemistry. Available from: https://www.psychologytoday.com/articles/201009/addiction-in-society-blinded-biochemistry. Accessed 13 August 2016 1 September.
Heim, D. 2014. Addiction: not just brain malfunction. Nature 507: 40.
Vrecko, S. 2010. Birth of a brain disease: science, the state and addiction neuropolitics. History of the Human Sciences 23: 52–67.
Wood, E., J.H. Samet, and N.D. Volkow. 2013. Physician education in addiction medicine. JAMA 310: 1673–1674.
Volkow, N.D., G.F. Koob, and A.T. McLellan. 2016. Neurobiologic advances from the brain disease model of addiction. New England Journal of Medicine 374: 363–371.
Volkow, N.D., and T.K. Li. 2005. The neuroscience of addiction. Nature Neuroscience 8: 1429–1430.
Volkow, N.D., G.F. Koob, and A.T. McLellan. 2016. Supplementary appendix to ‘Neurobiologic advances from the brain disease model of addiction’. New England Journal of Medicine 374: 363–371.
Volkow, N.D., and G. Koob. 2015. Brain disease model of addiction: why is it so controversial? Lancet Psychiatry 2: 677–679.
Heilig, M. 2015. The thirteenth step: addiction in the age of brain science. New York: Columbia University Press.
Koob, G.F., G.K. Lloyd, and B.J. Mason. 2009. Development of pharmacotherapies for drug addiction: a Rosetta stone approach. Nature Reviews Drug Discovery 8: 500–515.
Leshner, A.I. 1997. Addiction is a brain disease, and it matters. Science 278: 45–47.
Volkow, N.D., and T.K. Li. 2004. Drug addiction: the neurobiology of behaviour gone awry. Nature Reviews Neuroscience 5: 963–970.
Dackis, C., and C. O'Brien. 2005. Neurobiology of addiction: treatment and public policy ramifications. Nature Neuroscience 8: 1431–1436.
Levy, N. 2013. Addiction is not a brain disease (and it matters). Frontiers in Psychiatry 4: 24.
Koob, G.F., and M. Le Moal. 2006. Neurobiology of addiction. New York: Academic Press.
Heyman, G.M. 2013. Quitting drugs: quantitative and qualitative features. Annual Review of Clinical Psychology 9: 29–59.
Ahmed, S.H. 2010. Validation crisis in animal models of drug addiction: beyond non-disordered drug use toward drug addiction. Neuroscience and Biobehavioral Reviews 35: 172–184.
Kalant, H. 2015. Neurobiological research on addiction: what value has it added to the concept? International Journal of Alcohol and Drug Research 4: 53–59.
Ioannidis, J.P. 2011. Excess significance bias in the literature on brain volume abnormalities. Archives of General Psychiatry 68: 773–780.
Eklund, A., T.E. Nichols, and H. Knutsson. 2016. Cluster failure: why fMRI inferences for spatial extent have inflated false-positive rates. Proceedings of the National Academy of Sciences of the United States of America 113: 7900–7905.
Lewis, M. 2017. Addiction and the brain: development, not disease. Neuroethics. doi:10.1007/s12152-016-9293-4
Hyman, S., and E. Addiction. 2005. A disease of learning and memory. American Journal of Psychiatry 162: 1414–1422.
Hyman, S.E., R.C. Malenka, and E.J. Nestler. 2006. Neural mechanisms of addiction: the role of reward-related learning and memory. Annual Review of Neuroscience 29: 565–598.
Koob, G.F., and M.J. Kreek. 2007. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. American Journal of Psychiatry 164: 1149–1159.
Koob, G.F., and M. Le Moal. 2005. Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction. Nature Neuroscience 8: 1442–1444.
Koob, G.F. 2006. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction 101(Suppl 1): 23–30.
Bennett, M.R., and P.M.S. Hacker. 2003. Philosophical foundations of neuroscience. Malden: Blackwell.
Best, D., W. Dawson, G. De Leon, B. Kidd, T. McSweeney, M. Gilman, et al. 2010. Tackling addiction: pathways to recovery. London: Jessica Kingsley.
Volkow, N.D., and T.-K. Li. 2005. Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences. Pharmacology and Therapeutics 108: 3–17.
National Academies of Sciences Engineering and Medicine. 2016. Ending discrimination against people with mental and substance use disorders: the evidence for stigma change. Washington, DC: The National Academies Press.
Phelan, J.C., and B.G. Link. 2012. Genetics, addiction and stigma. In Genetic research on addiction: ethics, the law and public health, ed. A. Chapman, 174–194. New York: Cambridge University Press.
Meurk, C., K. Morphett, A. Carter, M. Weier, J. Lucke, and W. Hall. 2016. Scepticism and hope in a complex predicament: people with addictions deliberate about neuroscience. International Journal of Drug Policy 32: 34–43.
Bell, S., A. Carter, R. Mathews, C. Gartner, J. Lucke, and W. Hall. 2014. Views of addiction neuroscientists and clinicians on the clinical impact of a brain disease model of addiction. Neuroethics 7(1): 19–27.
Barnett, A.I., and C.L. Fry. 2015. The clinical impact of the brain disease model of alcohol and drug addiction: exploring the attitudes of community-based AOD clinicians in Australia. Neuroethics 8(3): 271–282.
Adrian Carter received an Australian Research Council Discovery Early Career Researcher Award (No. DE140101097).
Rights and permissions
About this article
Cite this article
Hall, W., Carter, A. & Barnett, A. Disease or Developmental Disorder: Competing Perspectives on the Neuroscience of Addiction. Neuroethics 10, 103–110 (2017). https://doi.org/10.1007/s12152-017-9303-1
- Brain disease